Schedule 13G/A
IOVA Schedule 13G/A filing by BlackRock
BlackRock reported beneficial ownership of 33.4M shares, representing 12% of IOVANCE BIOTHERAPEUTICS INC in this filing.
FiledJul 28, 2026
Ownership dateJun 30, 2026
Reported shares33.4M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
32.8M
Shared voting power
33.4M
Sole dispositive power
33.4M
Shared dispositive power
33.4M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$4.70as of Jul 28, 2026
Latest tracked price$4.47as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- BlackRock
- CIK
- CIK0002012383
- Accession
- 0002012383-26-002600
- Form
- Schedule 13G/A
Read the filing in context